Clinical Trial Update: The Favorable Impact of HBcAb Positive Grafts on Liver Transplantation for HBV-related HCC

View source ↗

Summary

A completed clinical trial update reports favorable outcomes with HBcAb-positive donor grafts in liver transplantation for HBV-related hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Xiao Xu | Conditions: Liver Transplantation | Status: COMPLETED